Literature DB >> 21329882

The MK5/PRAK kinase and Myc form a negative feedback loop that is disrupted during colorectal tumorigenesis.

Theresia R Kress1, Ian G Cannell, Arjan B Brenkman, Birgit Samans, Matthias Gaestel, Paul Roepman, Boudewijn M Burgering, Martin Bushell, Andreas Rosenwald, Martin Eilers.   

Abstract

Expression of the Myc oncoprotein is downregulated in response to stress signals to allow cells to cease proliferation and escape apoptosis, but the mechanisms involved in this process are poorly understood. Cell cycle arrest in response to DNA damage requires downregulation of Myc via a p53-independent signaling pathway. Here we have used siRNA screening of the human kinome to identify MAPKAPK5 (MK5, PRAK) as a negative regulator of Myc expression. MK5 regulates translation of Myc, since it is required for expression of miR-34b and miR-34c that bind to the 3'UTR of MYC. MK5 activates miR-34b/c expression via phosphorylation of FoxO3a, thereby promoting nuclear localization of FoxO3a and enabling it to induce miR-34b/c expression and arrest proliferation. Expression of MK5 in turn is directly activated by Myc, forming a negative feedback loop. MK5 is downregulated in colon carcinomas, arguing that this feedback loop is disrupted during colorectal tumorigenesis.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21329882     DOI: 10.1016/j.molcel.2011.01.023

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  71 in total

Review 1.  MYC: connecting selective transcriptional control to global RNA production.

Authors:  Theresia R Kress; Arianna Sabò; Bruno Amati
Journal:  Nat Rev Cancer       Date:  2015-09-18       Impact factor: 60.716

2.  IGF2BP1 promotes cell migration by regulating MK5 and PTEN signaling.

Authors:  Nadine Stöhr; Marcel Köhn; Marcell Lederer; Markus Glass; Claudia Reinke; Robert H Singer; Stefan Hüttelmaier
Journal:  Genes Dev       Date:  2012-01-15       Impact factor: 11.361

3.  The MYC mRNA 3'-UTR couples RNA polymerase II function to glutamine and ribonucleotide levels.

Authors:  Francesca R Dejure; Nadine Royla; Steffi Herold; Jacqueline Kalb; Susanne Walz; Carsten P Ade; Guido Mastrobuoni; Jens T Vanselow; Andreas Schlosser; Elmar Wolf; Stefan Kempa; Martin Eilers
Journal:  EMBO J       Date:  2017-04-13       Impact factor: 11.598

4.  mTORC2 in the center of cancer metabolic reprogramming.

Authors:  Kenta Masui; Webster K Cavenee; Paul S Mischel
Journal:  Trends Endocrinol Metab       Date:  2014-05-21       Impact factor: 12.015

5.  Cross-Phosphorylation and Interaction between Src/FAK and MAPKAP5/PRAK in Early Focal Adhesions Controls Cell Motility.

Authors:  Sheila Figel Dwyer; Irwin H Gelman
Journal:  J Cancer Biol Res       Date:  2014-05-14

Review 6.  FOXOs: signalling integrators for homeostasis maintenance.

Authors:  Astrid Eijkelenboom; Boudewijn M T Burgering
Journal:  Nat Rev Mol Cell Biol       Date:  2013-01-17       Impact factor: 94.444

7.  p38-Regulated/activated protein kinase plays a pivotal role in protecting heart against ischemia-reperfusion injury and preserving cardiac performance.

Authors:  Yu Tina Zhao; Jianfeng Du; Naohiro Yano; Hao Wang; Jianguo Wang; Patrycja M Dubielecka; Ling X Zhang; Gangjian Qin; Shougang Zhuang; Paul Y Liu; Y Eugene Chin; Ting C Zhao
Journal:  Am J Physiol Cell Physiol       Date:  2019-07-10       Impact factor: 4.249

8.  MicroRNA-based screens for synthetic lethal interactions with c-Myc.

Authors:  Youjun Li; Yahui Zhu; Edward V Prochownik
Journal:  RNA Dis       Date:  2016-05-30

9.  OmoMYC blunts promoter invasion by oncogenic MYC to inhibit gene expression characteristic of MYC-dependent tumors.

Authors:  L A Jung; A Gebhardt; W Koelmel; C P Ade; S Walz; J Kuper; B von Eyss; S Letschert; C Redel; L d'Artista; A Biankin; L Zender; M Sauer; E Wolf; G Evan; C Kisker; M Eilers
Journal:  Oncogene       Date:  2016-10-17       Impact factor: 9.867

Review 10.  MYC, Metabolism, and Cancer.

Authors:  Zachary E Stine; Zandra E Walton; Brian J Altman; Annie L Hsieh; Chi V Dang
Journal:  Cancer Discov       Date:  2015-09-17       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.